Genetic disorders in maternal medicine

The role of genetic testing within maternal medicine is expanding. Advancing technology and the increasing availability of genetic testing have seen more patients receiving a genetic diagnosis than ever before. Improved healthcare and understanding of these rare diseases means that many patients are living well into their reproductive years and starting families. Individual diseases are considered by their patterns of inheritance i.e. autosomal recessive, autosomal dominant and chromosomal diseases. This chapter specifically addresses the following examples and outlines an approach to pre-conceptual and pregnancy management; - Autosomal recessive o Cystic fibrosis o Phenylketonuria - Autosomal dominant o Osteogenesis imperfecta o Vascular Ehlers-Danlos syndrome - Chromosomal o Turner syndrome - Autosomal recessive o Cystic fibrosis o Phenylketonuria - Autosomal dominant o Osteogenesis imperfecta o Vascular Ehlers-Danlos syndrome - Chromosomal o Turner syndrome For many rare and ultrarare genetic diseases, there may be no clear guidelines or consensus on the correct management in pregnancy. This chapter seeks to provide a framework for the clinician to use to address the unique needs and risk profile of these patients in pregnancy and pre-conceptually and plan accordingly. The role of pharmacogenetics in maternal medicine, the future of education in genetics for patients and clinicians and the important role of genetic counselling are all considered in this chapter. This overview highlights the important role of genetics in maternal medicine and how this can inform management and planning for the safe care of mother and baby. Very rare or ultra-rare genetic diseases pose a significant challenge for patients and clinicians pre-conceptually and during pregnancy. Here, international collaboration concerning the management of these conditions in pregnancy can play an important role.